Cristina Almansa
Overview
Explore the profile of Cristina Almansa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
407
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song X, Chen Y, Perry A, Kagan J, Bhandari S, Almansa C, et al.
Gastro Hep Adv
. 2024 Aug;
1(6):954-962.
PMID: 39131254
Background And Aims: To quantify the indirect burden of cyclic vomiting syndrome (CVS), we assessed work-related productivity loss in patients with CVS and caregivers using large-sized databases in the United...
2.
Di Lorenzo C, Nurko S, Hyams J, Rodriguez-Araujo G, Almansa C, Shakhnovich V, et al.
J Pediatr Gastroenterol Nutr
. 2024 Mar;
78(5):1059-1068.
PMID: 38533633
Objectives: Linaclotide, a guanylate cyclase-C agonist, was recently approved in the United States for treatment of children 6-17 years old with functional constipation (FC). This study evaluated the safety and...
3.
Brenner D, Lacy B, Ford A, Bartolini W, Wu J, Shea E, et al.
Am J Gastroenterol
. 2022 Oct;
118(5):872-879.
PMID: 36227782
Introduction: These post hoc analyses provide clinically relevant data concerning time to response for individual irritable bowel syndrome with constipation (IBS-C) symptoms after linaclotide use. Methods: Time-to-response data were pooled...
4.
Mukker J, Dukes G, Tolkoff M, Wang L, Almansa C, Huh S, et al.
Clin Transl Sci
. 2022 Apr;
15(6):1532-1543.
PMID: 35460165
Trazpiroben is a dopamine D /D receptor antagonist under development for the treatment of gastroparesis. This phase I, open-label, randomized, two-way crossover study (NCT04121078) evaluated the effect of single-dose intravenous...
5.
Chen C, Zhang L, Almansa C, Rosario M, Cwik M, Balani S, et al.
Clin Pharmacol Drug Dev
. 2022 Jan;
11(2):142-149.
PMID: 34989180
The 5-hydroxytryptamine type-4 receptor agonist felcisetrag (TAK-954) is being investigated for improving gastrointestinal motility in postoperative gastrointestinal dysfunction. Polypharmacy often occurs in this setting, and as in vitro data indicate,...
6.
Ye Y, Yin Y, Huh S, Almansa C, Bennett D, Camilleri M
Gastroenterology
. 2021 Oct;
162(1):109-121.e5.
PMID: 34624355
Background & Aims: Although gastroparesis carries a considerable health care and patient burden, associated epidemiological data are limited. To provide new real-world evidence for gastroparesis, we estimated disease prevalence, and...
7.
Chen C, Zhang W, Bari M, Almansa C, Baratta M, Rosario M
Clin Pharmacol
. 2021 Jul;
13:145-155.
PMID: 34285598
Purpose: Treatment options for gastroparesis, such as metoclopramide and domperidone, are limited because of safety concerns, which may be exacerbated in the presence of inhibitors of drug metabolism. This study...
8.
Chedid V, Brandler J, Arndt K, Vijayvargiya P, Wang X, Burton D, et al.
Aliment Pharmacol Ther
. 2021 Mar;
53(9):1010-1020.
PMID: 33711180
Background: Gastroparesis is defined by delayed gastric emptying with associated symptoms in the absence of mechanical obstruction. Aim: To evaluate pharmacokinetics and pharmacodynamics of felcisetrag, a highly selective 5-HT receptor...
9.
Heyland D, Ortiz A, Stoppe C, Patel J, Yeh D, Dukes G, et al.
Crit Care Med
. 2020 Nov;
49(1):49-59.
PMID: 33148950
Objectives: To determine the incidence of enteral feed intolerance, identify factors associated with enteral feed intolerance, and assess the relationship between enteral feed intolerance and key nutritional and clinical outcomes...
10.
Ye Y, Jiang B, Manne S, Moses P, Almansa C, Bennett D, et al.
Gut
. 2020 Jun;
70(4):644-653.
PMID: 32493829
Objective: To generate real-world evidence for the epidemiology of gastroparesis in the UK, we evaluated the prevalence, incidence, patient characteristics and outcomes of gastroparesis in the Clinical Practice Research Datalink...